Gene · 3184
HNRNPD: heterogeneous nuclear ribonucleoprotein D
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. HNRNPD: heterogeneous nuclear ribonucleoprotein D. Genes, record 3184. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3184
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q14103 | Heterogeneous nuclear ribonucleoprotein D0 | 355 | 7 | Ensembl, GeneID, HGNC |
Source UniProt
Patents75
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 4890 | Q14103 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 4469 | Q14103 | Espacenet |
| JP 2025523953 A | 2025-07-25 | 14 | Q14103 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 4469 | Q14103 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 4890 | Q14103 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 6438 | Q14103 | Espacenet |
| US 12023371 B2 | 2024-07-02 | 4640 | Q14103 | Espacenet |
| EP 4373528 A2 | 2024-05-29 | 14 | Q14103 | Espacenet |
| US 11860162 B2 | 2024-01-02 | 1331 | Q14103 | Espacenet |
| US 11694765 B2 | 2023-07-04 | 128 | Q14103 | Espacenet |
1 to 10 of 75
See all 75 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,535
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | HNRNPD papers | Newest fiscal year |
|---|---|---|---|
| ZIAAG000511 | Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis | 36 | 2025 |
| ZIAAG000393 | Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging | 24 | 2025 |
| R01DK057819 | Intestinal Mucosal Growth in Health and Surgical Diseases | 13 | 2025 |
| ZICAG000616 | Analysis of complex biological systems by high-throughput genomic technologies | 11 | 2025 |
| ZIAES090080 | TTP and related proteins in the regulation of gene expression | 10 | 2025 |
| I01BX000332 | Posttranscriptional Control of Gut Mucosal Defense and Homeostasis | 7 | 2025 |
| P30CA062203 | Cancer Center Support Grant | 7 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| T32AI007401 | Training Program in Immunology and Pathogenesis | 6 | 2025 |
| ZIAAG000394 | Post-transcriptional regulation of energy usage: glucose and lipid metabolism | 6 | 2025 |
1 to 10 of 1,535Source NIH's project files
See all 1,535 nih grantsPapers2,430
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction: Splicing-mediated control of hnRNPD isoform switching by SRSF2 drives PD-L1-dependent immune evasion in gallbladder cancer. | Oncogene | 2026 | 42773214 | PubTator, text mining | PubMed |
| RNA-binding protein hnRNPD promotes the proliferation of Wilms' tumor cells through activating the p38 MAPK signaling pathway. | Neoplasma | 2026 | 42578483 | PubTator, text mining | PubMed |
| Splicing factor HNRNPD and alternative splicing of MAP4K4 are associated with cell apoptosis and immune microenvironment features in Wilms' tumor. | PLoS One | 2026 | 42560952 | PubTator, text mining | PubMed |
| Splicing-mediated control of hnRNPD isoform switching by SRSF2 drives PD-L1-dependent immune evasion in gallbladder cancer. | Oncogene | 2026 | 42477458 | PubTator, text mining | PubMed |
| Correction: Copy number amplification-induced overexpression of lncRNA LOC101927668 facilitates colorectal cancer progression by recruiting hnRNPD to disrupt RBM47/p53/p21 signaling. | J Exp Clin Cancer Res | 2026 | 42381075 | PubTator, text mining | PubMed |
| RNA-Binding Proteins in Ageing and Age-Related Disease. | Neurol Int | 2026 | 42347120 | PubTator, text mining | PubMed |
| RNA-binding proteins in aging and age-related diseases: roles, mechanisms, and a large language model analysis. | Biogerontology | 2026 | 42322462 | PubTator, text mining | PubMed |
| DNMT3L affects synaptic function and induces neurobehavioral alterations in Drosophila via Sqd. | Neurobiol Dis | 2026 | 42320545 | PubTator, text mining | PubMed |
| RNA-binding protein hnRNPD induces epithelial-mesenchymal transition in Wilms' tumor via facilitating MAP4K4 mRNA stability. | Mol Genet Genomics | 2026 | 42234174 | PubTator, text mining | PubMed |
| AUF1 modulates cellular senescence in auditory hair cells by regulating the transcription and alternative splicing of immune response genes. | Mol Biol Rep | 2026 | 42189329 | PubTator, text mining | PubMed |
1 to 10 of 2,430
See all 2,430 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3184
GET https://conductscience.org/api/genes/v1/3184/patents?page=2